Description: Verici Dx plc engages in developing and commercializing clinical diagnostics kidney transplant tests. The company was incorporated in 2020 and is based in Penarth, United Kingdom. As of July 10, 2020, Verici Dx plc is a former subsidiary of Renalytix AI plc.
Home Page: www.vericidx.com
VRCI Technical Analysis
Avon House
Penarth,
CF64 2EZ
United Kingdom
Phone:
44 207 9338780
Officers
| Name | Title |
|---|---|
| Ms. Sara Barrington A.C.A., A.C.I.M. | CEO & Exec. Director |
| Mr. David M. Anderson | Chief Financial Officer |
| Mr. Salim Hamir F.C.A. | Company Sec. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.4758 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 13 |